Suppr超能文献

肝移植治疗肝细胞癌后发生咽部转移:病例报告及文献复习。

Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.

机构信息

Department of Hepato-Biliary-Pancreatic and Breast Surgery, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.

Department of Surgery, Kurashiki Medical Center, Bakuro-cho, Kurashiki, Okayama, 710-8522, Japan.

出版信息

World J Surg Oncol. 2020 May 28;18(1):109. doi: 10.1186/s12957-020-01873-0.

Abstract

BACKGROUND

The most common sites of recurrence after liver transplantation for hepatocellular carcinoma (HCC) have been reported to be the liver, lung, bone, and adrenal glands, but there have also been many reports of cases of multiple recurrence. The prognosis after recurrence is poor, with reported median survival after recurrence of HCC ranging from 9 to 19 months. Here, we report a case of long-term survival after recurrence of pharyngeal metastasis following living-donor liver transplantation (LDLT) for HCC within the Milan criteria, by resection of the metastatic region and cervical lymph node dissection.

CASE PRESENTATION

A 47-year-old man with a Model End-stage Liver Disease (MELD) score of 11 underwent LDLT for HCC within the Milan criteria for liver cirrhosis associated with hepatitis B virus infection, with his 48-year-old elder brother as the living donor. One year and 10 months after liver transplantation, he visited a nearby hospital with a chief complaint of discomfort on swallowing. A pedunculated polyp was found in the hypopharynx, and biopsy revealed HCC metastasis. We performed pharyngeal polypectomy. Two years later, cervical lymph node metastasis appeared, and neck lymph node dissection was performed. Although recurrence subsequently occurred three times in the grafted liver, the patient is still alive 12 years and 10 months after recurrence of pharyngeal metastasis. He is now a tumor-free outpatient taking sorafenib.

CONCLUSION

It is necessary to recognize that the nasopharyngeal region is a potential site of HCC metastasis. Prognostic improvement can be expected with close follow-up, early detection, and multidisciplinary treatment, including radical resection.

摘要

背景

肝移植术后肝细胞癌(HCC)复发的最常见部位已报道为肝、肺、骨和肾上腺,但也有许多多次复发的病例报告。复发后的预后较差,据报道 HCC 复发后的中位生存时间为 9 至 19 个月。在此,我们报告了一例米兰标准内肝移植(LDLT)治疗 HCC 后复发为咽转移的长期生存病例,通过切除转移区域和颈部淋巴结清扫术。

病例介绍

一名 47 岁男性,MELD 评分为 11,因乙型肝炎病毒感染相关肝硬化行 LDLT,其 48 岁的哥哥作为活体供者。肝移植后 1 年 10 个月,因吞咽不适就诊于附近医院。发现下咽有一带蒂息肉,活检显示 HCC 转移。我们进行了咽息肉切除术。2 年后,出现颈部淋巴结转移,行颈部淋巴结清扫术。尽管随后在移植肝中复发了 3 次,但该患者在咽转移复发后 12 年 10 个月仍存活。他现在是一名无肿瘤的门诊患者,正在服用索拉非尼。

结论

有必要认识到鼻咽部是 HCC 转移的潜在部位。通过密切随访、早期发现和多学科治疗,包括根治性切除,可以预期预后改善。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验